Ventricular septal defect closure in a patient with VACTERL syndrome: anticipating sequelae in a rare genetic

Ali Can Hatemi1, Mete Gursoy, Kadir Ceviker

  • 1Department of Cardiovascular Surgery, Institute of Cardiology, Istanbul University, Haseki, Istanbul 34304, Turkey. hatemi@superonline.com

Insights

Genetic disorders complicate pediatric cardiac surgery. Closing a ventricular septal defect in a VACTERL syndrome patient improved outcomes, highlighting the importance of addressing noncardiac defects.

Area of Science:

  • Pediatric Cardiac Surgery
  • Medical Genetics
  • Congenital Heart Defects

Background:

  • Noncardiac anomalies in genetic disorders pose significant risks for pediatric cardiac surgery patients.
  • These patients face higher rates of prolonged hospitalization, increased costs, morbidity, and mortality.
  • Ventricular septal defect (VSD) is a common cardiac anomaly associated with various genetic syndromes.

Observation:

  • VACTERL syndrome, a rare pattern of birth defects, has a notable incidence of VSD (22.3%).
  • This case study focuses on a 4-month-old female infant diagnosed with VACTERL syndrome postnatally.
  • The patient underwent surgical closure of a ventricular septal defect.

Findings:

  • Surgical closure of the VSD was performed in the infant with VACTERL syndrome.
  • The impact of VSD closure on the patient's operative and postoperative course is discussed.
  • Addressing the VSD is crucial for managing complex pediatric cardiac surgery cases associated with genetic disorders.

Implications:

  • Effective management of noncardiac components, such as VSD in VACTERL syndrome, is vital for improving outcomes in pediatric cardiac surgery.
  • Early identification and surgical intervention for VSD in patients with genetic syndromes can mitigate complications.
  • This case underscores the need for a multidisciplinary approach to care for children with complex congenital conditions.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...